Treating Inflammation with a Binding System
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 8,790,640 | Treating Inflammation with a Binding System In force · Medium confidence | Liveleaf Holdings LLC. | In force | Medium confidence | ||
| US 8,722,040 | Site-activated binding systems that selectively increase the bioactivity of phenolic compounds at target sites Lapsed May 13, 2026 on the fee record Ended May 13, 2026 · Medium confidence | Liveleaf Holdings, LLC | Lapsed May 13, 2026 on the fee record | Ended May 13, 2026 | Ended May 13, 2026 | Medium confidence |
| Application 14/255,431 | Treating Inflammation with a Combination of an Ellagitannin and Hydrogen Peroxide Abandoned Abandoned Jan 27, 2017 | LiveLeaf, Inc. | Abandoned | Abandoned Jan 27, 2017 | not computed | |
| Application 14/702,700 | Killing Antibiotic-Resistant Bacteria with a Formulation That Is Safe for Oral Administration Abandoned Abandoned Oct 21, 2019 | LiveLeaf, Inc. | Abandoned | Abandoned Oct 21, 2019 | not computed | |
| Application 16/589,955 | Enhanced Antivirulent for Antibiotic-Resistant Bacteria Abandoned Abandoned Oct 3, 2022 | LiveLeaf, Inc. | Abandoned | Abandoned Oct 3, 2022 | not computed |
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Liveleaf Holdings LLC.
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.